AnaptysBio, Inc. ANAB
46.63 USD -0.77 (-1.62%)
Regular-session close
46.63 0.00 0.00%
After hours · Nov 20, 4:38 PM ET
46.05 Day range 47.66
25.11 52-week range 69.81
- YTD
- +44.28%
- 1 year
- +85.70%
ANAB revenue history
Revenue is income from the company’s ordinary business activities.
234,603,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 234,603,000 | 143,323,000 | 157.01% |
| FY 2024 | 2024-12-31 | 91,280,000 | 74,123,000 | 432.03% |
| FY 2023 | 2023-12-31 | 17,157,000 | 6,870,000 | 66.78% |
| FY 2022 | 2022-12-31 | 10,287,000 | -52,888,000 | -83.72% |
| FY 2021 | 2021-12-31 | 63,175,000 | -11,825,000 | -15.77% |
| FY 2020 | 2020-12-31 | 75,000,000 | 67,000,000 | 837.50% |
| FY 2019 | 2019-12-31 | 8,000,000 | 3,000,000 | 60.00% |
| FY 2018 | 2018-12-31 | 5,000,000 | -5,000,000 | -50.00% |
| FY 2017 | 2017-12-31 | 10,000,000 | -6,684,000 | -40.06% |
| FY 2016 | 2016-12-31 | 16,684,000 | -887,000 | -5.05% |
| FY 2015 | 2015-12-31 | 17,571,000 | 1,733,000 | 10.94% |
| FY 2014 | 2014-12-31 | 15,838,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-23T06:00:43.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
